This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of central nervous system (CNS) drugs, where its structural features contribute to the pharmacological activity of the final product. The trifluoro and methoxy groups enhance the compound's ability to interact with biological targets, making it a crucial building block in the creation of potent and selective therapeutic agents. Additionally, its unique chemical properties are leveraged in research settings for the design and optimization of new drug candidates, especially those targeting neurological disorders.